4',6-dihydroxyflavone has been researched along with ag 183 in 1 studies
| Studies (4',6-dihydroxyflavone) | Trials (4',6-dihydroxyflavone) | Recent Studies (post-2010) (4',6-dihydroxyflavone) | Studies (ag 183) | Trials (ag 183) | Recent Studies (post-2010) (ag 183) |
|---|---|---|---|---|---|
| 10 | 0 | 3 | 33 | 0 | 3 |
| Protein | Taxonomy | 4',6-dihydroxyflavone (IC50) | ag 183 (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 1.625 | |
| Platelet-derived growth factor receptor beta | Homo sapiens (human) | 2.8 | |
| Fibroblast growth factor receptor 1 | Homo sapiens (human) | 4.9 | |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 4.3 | |
| large T antigen | Betapolyomavirus macacae | 19.79 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CJ; Geahlen, RL | 1 |
1 review(s) available for 4',6-dihydroxyflavone and ag 183
| Article | Year |
|---|---|
Protein-tyrosine kinase inhibition: mechanism-based discovery of antitumor agents.
Topics: Animals; Antineoplastic Agents; Drug Screening Assays, Antitumor; Humans; Protein-Tyrosine Kinases | 1992 |